Page last updated: 2024-08-23

nicorandil and Acute Kidney Failure

nicorandil has been researched along with Acute Kidney Failure in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (62.50)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Fu, N; Yang, S; Zhang, P; Zhang, X1
Bellandi, F; Leoncini, M; Maioli, M; Toso, A1
El-Kashef, DH; Ezzat, DM; Soliman, AM1
Bao, H; Cheng, X; Huang, X; Jiang, L; Zhan, B1
Fu, N; Fu, X; Zeng, Z; Zhang, X1
Tian, ZL; Yao, L; Zhang, AQ; Zhang, YJ; Zhao, XX1
Kawasaki, M; Kinomura, Y; Minatoguchi, S; Nawa, T; Nishigaki, K; Tanaka, T; Yamada, Y1
Hejazi, SF; Iranirad, L; Jang, SA; Sadeghi, MS1

Reviews

2 review(s) available for nicorandil and Acute Kidney Failure

ArticleYear
Pharmacologic Prophylaxis of Contrast-Induced Nephropathy.
    Interventional cardiology clinics, 2020, Volume: 9, Issue:3

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Angiography; Contrast Media; Europe; Female; Fluid Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Revascularization; Nicorandil; Practice Guidelines as Topic; Risk Factors; Saline Solution, Hypertonic; Trimetazidine; Vasodilator Agents

2020
Effect of Nicorandil Administration on Preventing Contrast-Induced Nephropathy: A Meta-Analysis.
    Angiology, 2018, Volume: 69, Issue:7

    Topics: Acute Kidney Injury; Contrast Media; Coronary Angiography; Humans; Nicorandil; Percutaneous Coronary Intervention; Vasodilator Agents

2018

Trials

4 trial(s) available for nicorandil and Acute Kidney Failure

ArticleYear
Efficacy of nicorandil on the prevention of contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention.
    Coronary artery disease, 2020, Volume: 31, Issue:3

    Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Angina, Stable; Blood Urea Nitrogen; Contrast Media; Coronary Disease; Creatinine; Cystatin C; Female; Humans; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Vasodilator Agents

2020
Comparison of double-dose vs. usual dose of nicorandil for the prevention of contrast-induced nephropathy after cardiac catheterization.
    International urology and nephrology, 2019, Volume: 51, Issue:11

    Topics: Acute Kidney Injury; Aged; Cardiac Catheterization; Contrast Media; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicorandil; Prospective Studies

2019
Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
    International journal of cardiology, 2015, Sep-15, Volume: 195

    Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Cystatin C; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Function Tests; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Perioperative Care; Postoperative Complications; Protective Agents; Regression Analysis; Renal Insufficiency, Chronic; Treatment Outcome

2015
Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Cardiology journal, 2017, Volume: 24, Issue:5

    Topics: Acute Kidney Injury; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Fluid Therapy; Glomerular Filtration Rate; Humans; Iran; Kidney; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Prospective Studies; Renal Agents; Risk Factors; Time Factors; Treatment Outcome

2017

Other Studies

2 other study(ies) available for nicorandil and Acute Kidney Failure

ArticleYear
Nicorandil mitigates folic acid-induced nephrotoxicity in mice: Role of iNOS and eNOS.
    Journal of biochemical and molecular toxicology, 2021, Volume: 35, Issue:4

    Topics: Acute Kidney Injury; Animals; Dose-Response Relationship, Drug; Folic Acid; Male; Mice; Nicorandil; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III

2021
Nicorandil protects against ischaemia-reperfusion injury in newborn rat kidney.
    Pharmacology, 2013, Volume: 92, Issue:5-6

    Topics: Acute Kidney Injury; Animals; Animals, Newborn; Apoptosis; Cytokines; Disease Models, Animal; Inflammation; KATP Channels; Male; NF-kappa B; Nicorandil; Phosphatidylinositol 3-Kinases; Potassium Channels, Inwardly Rectifying; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Vasodilator Agents

2013